Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study
Open Access
- 19 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4), e0153927
- https://doi.org/10.1371/journal.pone.0153927
Abstract
The primary objective of this pilot study was to investigate whether the therapeutic drug monitoring of imipenem could be performed with spent effluent instead of blood sampling collected from critically ill patients under continuous renal replacement therapy. A prospective open-label study was conducted in a real clinical setting. Both blood and effluent samples were collected pairwise before imipenem administration and 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h after imipenem administration. Plasma and effluent imipenem concentrations were determined by reversed-phase high-performance liquid chromatography with ultraviolet detection. Pharmacokinetic and pharmacodynamic parameters of blood and effluent samples were calculated. Eighty-three paired plasma and effluent samples were obtained from 10 patients. The Pearson correlation coefficient of the imipenem concentrations in plasma and effluent was 0.950 (P<0.0001). The average plasma-to-effluent imipenem concentration ratio was 1.044 (95% confidence interval, 0.975 to 1.114) with Bland-Altman analysis. No statistically significant difference was found in the pharmacokinetic and pharmacodynamic parameters tested in paired plasma and effluent samples with Wilcoxon test. Spent effluent of continuous renal replacement therapy could be used for therapeutic drug monitoring of imipenem instead of blood sampling in critically ill patients.Keywords
Funding Information
- This study was funded by a grant from the Research Program of the Beijing Pharmaceutical Association
This publication has 53 references indexed in Scilit:
- Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter studyJournal of Infection and Chemotherapy, 2014
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic ReviewAnnals of Intensive Care, 2012
- Pharmacokinetic evaluation of piperacillin-tazobactamExpert Opinion on Drug Metabolism & Toxicology, 2010
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJama-Journal Of The American Medical Association, 2009
- Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detectionJournal of Chromatography B, 2008
- Adsorption of Amikacin, a Significant Mechanism of Elimination by HemofiltrationAntimicrobial Agents and Chemotherapy, 2008
- Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosingIntensive Care Medicine, 2006
- Renal replacement therapy in the intensive care unitTherapeutics and Clinical Risk Management, 2005
- Inadequate Antimicrobial Treatment of InfectionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999
- Stability and Kinetics of Degradation of Imipenem in Aqueous SolutionJournal of Pharmaceutical Sciences, 1990